How did Dada's revenue and expenses trend in Q4 2024?
4/14/2025 06:22am
Aime
Dada's revenue and expenses in Q4 2024 showed a gross profit of $333.28 million, with R&D expenses at $12.72 million and selling, general, and administrative expenses at $87.27 million1.
Source:
1.
DADA Revenue, Gross Profit, R&D Expenses, Sales and Marketing Expenses, General and Administrative Expenses in Q4 2024
more
less
For you
What are the short-term price targets set by analysts covering Pfizer?
What are the short-term technical indicators suggesting for Pfizer?
Is there any unusual options activity or capital flow surrounding Pfizer stock?
Are there any significant news or announcements expected for Pfizer that could impact its stock price?
How has Pfizer's stock performed compared to the overall market recently?
Explore
Screener
What are the best stocks to buy now?
Analysis
Aple Rating chart
Learn
Advanced technical indicators and how they are calculated and utilized